Abstract:Aim: To construct the bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor 165 (VEGF-165)genes. Methods: This experiment was conducted at the Common Experimental Flatform of Tongji Medical College, Huazhong University of Science and Technology from March 2005 to October 2005. 1 Through polymerase chain reaction, target gene segment of pcDNA3.1-BMP2 and pUC-CAGGS-VEGF165 were subcloned and new estriction enzyme cutting sites were inducted, then were directionally connected to eukaryotic expression vector pIRES, bicistronic mRNA of two target gene was expressed when constructing. Recombinant plasmid was identified through polymerase chain reaction, enzyme analysis and DNA sequencing. 2 Recombinant plasmid transfected in vitro mouse bone marrow stroma cell induced by liposome. The expression of BMP-2 and VEGF-165 genes was detected through reverse transcriptase-polymerase chain reaction. Results: 1 Construction and id entification of bicistronic eukaryotic expression plasmid pIRES-BMP2-VEGF165: Recombinant plasmid pIRES-BM P2-VEGF165 was treated with Xho I/Mlu I and Xba I /Not I. Electropherosis of 1% agarose showed that there were 1.2 kbp human BMP-2 band and 592 bp vascular endothelial growth factor 165 band enzyme band and the electropherosis band of polymerase chain reaction were placed in the same position. Polymerase chain reaction, enzyme analysis and DNA sequencing proved that the inserting segment direction of target gene was right and no mutation appeared in DNA sequencing. 2 Expression of BMP-2 and VEGF-165 mRNA: transfected pIRES empty plasmid was as negative control, RNA of transfected cells was extracted 48 hours later, then were performed reverse transcriptase-polymerase chain reaction with P1, P2, P3, and P4 as primer. Results demonstrated that mouse bone marrow stroma cell with transfected pIRES-HMP2-VEGF165 amplified 1.2 kbp and 592 bp two bands, which proved that this recombinant plasmid could co-express in vitro bicistronic eukaryotic expression plasmid containing BMP-2 and VEGF-165 mRNA. Conclusion: Bicistronic eukaryotic expression plasmids containing BMP-2 and VEGF-165 mRNA are constructed successfully, which provide the foundation for combination gene therapy in bone defect.

Construction and Identification of Bicistronic Eukaryotic Expression Plasmid Containing G250 of Renal Carcinoma and Hgm-Csf

Construction of a fusion expression plasmid containing the G250 gene and human granulocyte-macrophage colony stimulating factor and its significance in renal cell carcinoma.

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Construction of Eukaryotic Expression Fusion Plasmid of HPV6b E7 Gene and CRT Gene

Construction and Expression of the Eukaryotic Coexpression Plasmid Containing PML-RARα245 and Hgm-Csf Gene

A Tumor Targeted Gene Vector Modified with G250 Monoclonal Antibody for Gene Therapy

[Fusion Expression of Human Renal Cell Carcinoma-Associated Antigen G250/MN/CA IX in Prokaryotic Expression System].

Real-time Quantitative Reverse Transcription-Pcr Assay for Renal Cell Carcinoma-Associated Antigen G250

[Construction of Recombinant GST-RCAS1 Fusion Gene and Its Expression in E. Coli].

[Construction and Expression of Eukaryotic Coexpression Plasmid Containing Human MUC1 Gene and GM-CSF Gene].

Construction and in vitro expression of bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 and vascular endothelial growth factor 165 genes

Construction and Identification of Co-expression Gene Vaccine of GM-CSF and Somatostatin (SS)

Construction and Identification of the Recombinant Plasmid of Inhibition of Tumor Cell Cortical Actin Assembly Function

Construction and identification of a bicistronic eukaryotic expressional vector carrying the R132H mutated hIDH1 gene found in gliomas

Construction of Eukaryotic Expression Plasmid Containing Human Polymorphic Epithelial Mucin and Granulocyte Macrophage Colony Stimulating Factor

Construction and Identification of a Eukaryotic Expression Plasmid of Rat PDGF-C Gene

Construction of Pires2-Egfp-mgm Plasmid and Its Application in Preparing GM-CSF-secreting Tumor Vaccine

Construction and Identification of Recombinant Vectors Carrying Herpes Simplex Virus Thymidine Kinase and Cytokine Genes Expressed in Gastric Carcinoma Cell Line SGC7901

Construction of Eukaryotic Expression Plasmid Pegfp-N3-m-il-2(88 Arg,125 Ala) and Its Effects on Glioma Cell Line U87

Construction and identification of eukaryotic expression plasmid MCP-1

Construction of Eukaryotic Expression Vector Encoding Human Nasopharyngeal Carcinoma Anti-Idiotype Antibody Single Chain Fragment Gene G22 and Its Expression